In the last trading session, 3.75 million shares of the Novartis AG ADR (NYSE:NVS) were traded, and its beta was 0.54. Most recently the company’s share price was $97.28, and it changed around $2.16 or 2.27% from the last close, which brings the market valuation of the company to $190.33B. NVS currently trades at a discount to its 52-week high of $108.78, offering almost -11.82% off that amount. The share price’s 52-week low was $88.86, which indicates that the current value has risen by an impressive 8.66% since then. We note from Novartis AG ADR’s average daily trading volume that its 3-month average coming to 1.53 million.
Novartis AG ADR stock received a consensus recommendation rating of Hold, based on a mean score of 2.56. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended NVS as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Novartis AG ADR (NYSE:NVS) trade information
Instantly NVS has showed a green trend with a performance of 2.27% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -3.65% year-to-date, but still up 4.38% over the last five days. On the other hand, Novartis AG ADR (NYSE:NVS) is 1.09% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $108, which translates to bulls needing to increase their stock price by 9.93% from its current value. Analyst projections state that NVS is forecast to be at a low of $108 and a high of $108.
Novartis AG ADR (NVS) estimates and forecasts
Novartis AG ADR share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 2.75 percent over the past six months and at a 3.33% annual growth rate that is well below the industry average of 3.70%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 5.63%. Novartis AG ADR earnings are expected to increase by 9.73% in 2024, but the outlook is positive 6.67% per year for the next five years.
NVS Dividends
Novartis AG ADR’s next quarterly earnings report is expected to be released in May. The annual dividend yield of the stock is 3.84 percent and its annual dividend per share was 3.74. It is important to note, however, that the 3.84% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
